Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,486,562 | 2,505,950 | 2,833,470 | 2,426,390 | 1,888,460 |
| Marketable Securities | 874,095 | 765,160 | 568,480 | 756,750 | 789,350 |
| Receivables | 2,365,417 | 1,747,320 | 1,720,640 | 1,821,340 | 1,674,070 |
| Inventories | 1,682,960 | 1,763,020 | 1,720,450 | 1,735,450 | 1,643,080 |
| Other current assets | 0 | 618,100 | 527,820 | 569,940 | 509,680 |
| TOTAL | $6,409,034 | $7,399,550 | $7,370,860 | $7,309,870 | $6,504,640 |
| Non-Current Assets | |||||
| PPE Net | 3,654,875 | N/A | N/A | N/A | N/A |
| Investments And Advances | 53,419 | 7,280 | 8,170 | 8,290 | 7,880 |
| Intangibles | 259,161 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 414,834 | 773,190 | 545,110 | 662,940 | 600,430 |
| TOTAL | $4,382,289 | $780,470 | $553,280 | $671,230 | $608,310 |
| Total Assets | $10,791,320 | $12,092,050 | $11,782,470 | $11,874,900 | $10,820,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 67,523 | 65,600 | 321,480 | 170,800 | 184,860 |
| Accounts payable and accrued liabilities | 451,328 | 615,080 | 437,000 | 513,760 | 517,550 |
| Accrued Expenses | N/A | 218,850 | 368,790 | 430,190 | 274,730 |
| Other current liabilities | 2,929,225 | 2,984,040 | 2,740,180 | 2,475,030 | 2,370,440 |
| TOTAL | $3,877,366 | $3,883,590 | $3,867,450 | $3,589,800 | $3,347,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 90,089 | 93,820 | 95,380 | 97,270 | 92,430 |
| aiOther Non-Current Liabilities | 452,915 | 516,400 | 506,540 | 456,050 | 457,580 |
| TOTAL | $1,209,242 | $1,209,420 | $1,183,700 | $1,150,650 | $1,096,720 |
| Total Liabilities | $5,086,607 | $5,093,020 | $5,051,150 | $4,740,460 | $4,444,330 |
| Shareholders' Equity | |||||
| Common Shares | 102,254 | 108,400 | 110,200 | 111,940 | 110,040 |
| Retained earnings | 5,515,898 | 6,936,040 | 6,625,110 | 7,024,810 | 6,099,510 |
| Other shareholders' equity | 91,563 | -41,410 | 10 | -320 | 171,900 |
| TOTAL | $5,704,715 | $6,999,030 | $6,731,320 | $7,134,430 | $6,376,450 |
| Total Liabilities And Equity | $10,791,322 | $12,092,050 | $11,782,470 | $11,874,890 | $10,820,780 |